Abstract:Brain disorders represent a significant challenge in medical science due to the formidable blood‐brain barrier (BBB), which severely limits the penetration of conventional therapeutics, hindering effective treatment strategies. This review delves into the innovative realm of biomimetic nanodelivery systems, including stem cell‐derived nanoghosts, tumor cell membrane‐coated nanoparticles, and erythrocyte membrane‐based carriers, highlighting their potential to circumvent the BBB's restrictions. By mimicking native cell properties, these nanocarriers emerge as a promising solution for enhancing drug delivery to the brain, offering a strategic advantage in overcoming the barrier's selective permeability. We evaluate the unique benefits of leveraging cell membranes from various sources and examine advanced technologies for fabricating cell membrane‐encapsulated nanoparticles capable of masquerading as endogenous cells. This enables the targeted delivery of a broad spectrum of therapeutic agents, ranging from small molecule drugs to proteins, thereby providing an innovative approach to neurocare. Furthermore, the review contrasts the capabilities and limitations of these biomimetic nanocarriers with traditional delivery methods, underlining their potential to enable targeted, sustained, and minimally invasive treatment modalities. We conclude with a perspective on the clinical translation of these biomimetic systems, underscoring their transformative impact on the therapeutic landscape for intractable brain diseases. This article is protected by copyright. All rights reserved

Macrophages as Nanocarriers for Drug Delivery: Novel Therapeutics for Central Nervous System Diseases.

Nanoparticle Delivery for Central Nervous System Diseases and Its Clinical Application

Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.

Current Development of Nano-Drug Delivery to Target Macrophages

Strategies for transporting nanoparticles across the blood-brain barrier.

Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

Nanoparticles-based delivery system and its potentials in treating central nervous system disorders

Drug Delivery to the Brain Across the Blood-Brain Barrier Using Nanomaterials.

Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.

Exploiting Macrophages As Targeted Carrier to Guide Nanoparticles into Glioma

Nanocarriers As a Powerful Vehicle to Overcome Blood-Brain Barrier in Treating Neurodegenerative Diseases: Focus on Recent Advances

Recent Advances of Drug Nano-carriers Based on Central Nervous System

Micro/nanosystems for Controllable Drug Delivery to the Brain

Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System

Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities

Research Advances in Brain-Targeted Nanoscale Drug Delivery System

Immune cells: potential carriers or agents for drug delivery to the central nervous system

Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review

Engineering advanced nanomedicines against central nervous system diseases

Revolutionizing Neurocare: Biomimetic Nanodelivery via Cell Membranes

Recent Advances on Drug Delivery Nanocarriers for Cerebral Disorders.